BSD deploys hyperthermia system in China

Sarah Lamberti | | Health Imaging | Oncology Imaging
Liuan People's Hospital in Liuan City, China, has purchased a BSD-2000 hyperthermia system from BSD Medical Systems.

The new BSD-2000 delivers precision-focused radiofrequency (RF) energy into cancerous tumors, including those located deep in the body. The RF energy raises the tumor temperature to levels used to administer hyperthermia therapy and destroy cancer cells and can increase the effectiveness of radiation therapy.

Liuan People's Hospital plans to treat cervical cancer and other pelvic cancers as well as to conduct research on the treatment of lung cancer with the new BSD-2000 system, which is restricted to investigational use in the United States.


Sarah Lamberti

Related Content

MRI-first approach could allow many to safely forego prostate biopsy
MRI guidance significantly reduces radiotherapy side effects compared to CT
Interventional procedure often as effective as surgery for difficult-to-treat liver cancer
AI tumor volume estimations could improve prostate cancer treatment strategies
MRI could be 'powerful tool' for guiding surgery decisions in patients with rectal cancer
Breast cancer only visible via MRI is often less aggressive

Around the web

Radiology Business
The biggest challenges facing radiology business managers in 2025

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.